Acute intracranial hypertension requires aggressive treatment with physiologic and pharmacologic measures guided by intracranial pressure monitoring devices. Therapy involves the use of diuretics, corticosteroids, and barbiturates in combination with hyperventilation, ventricular drainage, and general supportive measures. This review focuses on the pathophysiology of increased intracranial pressure and the pharmacologic agents used in its management.
MarshallLFSmithRWShapiroHM. The outcome with aggressive treatment in severe head injuries. Part 1: The significance of intracranial pressure monitoring. J Neurosurg1979; 50: 20–5.
2.
KuhlDEReivichMAlaviANyaryIStaumMM. Local cerebral blood volume determined by three-dimensional reconstruction of radionuclide scan data. Clin Res1975; 36: 610–9.
BruceDA. The pathophysiology of increased intracranial pressure. Kalamazoo, MI: The Upjohn Company, 1978: 28–33.
5.
MillerJDBeckerDP. General principles and pathophysiology of head injury. In: YoumansJR, ed. Neurological surgery. Vol. 4. Philadelphia: WB Saunders, 1982: 1916–27.
MarshallLFSmithRWShapiroHM. The influence of diurnal rhythms in patients with intracranial hypertension: Implications for management. Neurosurgery1978; 2: 100–2.
8.
LundbergN. Continuous recording and control of ventricular fluid pressure in neurosurgical practice. Acta Psych Neurol Scand1960; 36 (suppl) 149.
9.
VriesJKBeckerDPYoungHF. A subarachnoid screw for monitoring intracranial pressure. J Neurosurg1973; 39: 416–9.
10.
BruceDABermanWASchutL. Cerebrospinal fluid pressure monitoring in children. Physiology, pathology, and clinical usefulness. In: Advances in pediatrics. Vol. 24. New York: Yearbook Medical Publishers, 1977: 223–90.
11.
BruceDAGoldbergASchutL. ICP monitoring in critical care pediatrics. Intensive Care Med1977; 3: 184–7.
12.
BruceDAGennarelliTALangfittTW. Resuscitation from coma due to head injury. Crit Care Med1978; 6: 254–68.
13.
PapoICaruselliGLuongoA. CSF withdrawal for the treatment of intracranial hypertension in acute head injuries. Acta Neurochir1981; 56: 191–9.
14.
HeffnerJESahnSA. Controlled hyperventilation in patients with intracranial hypertension. Arch Intern Med1983; 143: 765–9.
15.
CottrellJEPatelKPTurndorfHRansohoffJ. Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg1978; 48: 329–31.
16.
TurnesJMPowellDGibsonRMMcDowaldDG. Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimethaphan. Br J Anaesth1977; 49: 419–24.
17.
CottrellJEGupaBRappaportHIntracranial pressure during nitroglycerine-induced hypotension. J Neurosurg1980; 53: 309–11.
18.
ChestnutJSAlbinMSGonzalez-AbolaENewfieldPMaroonJC. Critical evaluation of intravenous nitroglycerin for neurosurgery. J Neurosurg1978; 48: 704–11.
19.
GagnonRLMarshMLSmithRWShapiroHM. Intracranial hypertension caused by nitroglycerin. Anesthesiology1979; 51: 86–7.
20.
FishmanRA. Brain edema. N Engl J Med1975; 293: 706–11.
21.
HooshmandHDoveJHouffSSuterC. Effects of diuretics and steroids on CSF pressure. Arch Neurol1969; 21: 499–509.
22.
JavidM. Urea—new use of an old agent. Reduction of intracranial and intraocular pressure. Surg Clin North Am1958; 38: 907–28.
23.
de los ReyesRAAusmanJIDiazFG. Agents for cerebral edema. In: Clinical neurosurgery. Vol. 28. Baltimore: Williams and Wilkins, 1980: 98–107.
24.
NewmanSLCaplanDBAhmannPA. Reye's syndrome: Success of supportive care (letter). N Engl J Med1978; 299: 1079.
BruceDALangfittTWMillerJD. Regional cerebral flow, intracranial pressure and brain metabolism in comatose patients. J Neurosurg1973; 38: 131–44.
31.
CantoreGPGuidettiBVernoM. Oral glycerol for the reduction of intracranial pressure. J Neurosurg1964; 21: 278–83.
32.
MeyerJSItohYOkamotoSCirculatory and metabolic effects of glycerol infusion in patients with recent cerebral infarction. Circulation1975; 51: 701–12.
33.
ZwetnewNN. Effects of increased CSF pressure on the blood flow and on the energy metabolism of the brain. Acta Physiol Scand1970; 139 (suppl): 1–31.
34.
HagnevikKGordonELinsLEWilhelmssonSForsterD. Glycerol-induced haemolysis with hemoglobinuria and acute renal failure. Lancet1974; 1: 75–7.
35.
GilsanzVReballarJLBuencuerpoJChantresMT. Controlled trial of glycerol versus dexamethasone in the treatment of cerebral edema in acute cerebral infarction. Lancet1975; 1: 1049–51.
36.
MacDonaldJTUdenDL. Intravenous glycerol and mannitol therapy in children with intracranial hypertension. Neurology1982; 32: 437–40.
37.
PitlickWHPirikitakuhlrPPainterMJWesselHB. Effects of glycerol and hyperosmolarity on intracranial pressure. Clin Pharmacol Ther1982; 31: 466–71.
38.
NahataMCKerznerBMcClungHJSherardESHiltyMD. Variations in a glycerol kinetics in Reye's syndrome. Clin Pharmacol Ther1981; 29: 782–7.
39.
WaldSLMcLaurenRL. Oral glycerol for the treatment of traumatic intracranial hypertension. J Neurosurg1982; 56: 323–31.
40.
TourtellotteWWReinglassJLNewkirkTA. Cerebral dehydration action of glycerol. I. Historical aspects with emphasis on the toxicity and intravenous administration. Clin Pharmacol Ther1972; 13: 159–72.
41.
NewkirkTATourtellotteWWReinglassJL. Prolonged control of increased intracranial pressure with glycerin. Arch Neurol1972; 27: 95–6.
42.
SloviterHAShimkinPSuharaK. Glycerol as a substitute for brain metabolism. Nature1966; 210: 1334–6.
43.
BorchgrevinkCFHavelRJ. Transport of glycerol in human blood. Proc Soc Exp Biol Med1963; 113: 946–9.
44.
MudgeGH. Diuretics and other agents employed in the mobilization of edema. In: GilmanAGGoodmanLSGilmanA, eds. The pharmacologic basis of therapeutics. New York: Macmillan, 1980: 903–4.
45.
ReulenHJTsuyumuMTackAFenskeARPrioleauGR. Clearance of edema fluid into cerebrospinal fluid. A mechanism for resolution of vasogenic brain edema. J Neurosurg1979; 48: 754–64.
46.
TornheimPAMcLaurenRLSawayaR. Effect of furosemide on experimental traumatic cerebral edema. Neurosurgery1979; 4: 48–52.
47.
BuhrleyLEReedDJ. The effect of furosemide on sodium-22 uptake into cerebrospinal fluid and brain. Exp Brain Res1972; 14: 503–10.
48.
YenJKBourkeRSPoppAJNelsonLR. Use of ethacrynic acid in the treatment of serious head injury. In: PoppAJ, ed. Neurological trauma. New York: Raven Press, 1979: 329–39.
49.
BourkeRSKimelbergMADozeMAStudies on the formation of astroglial swelling and its inhibition by chemically useful agents. In: PoppAJBourkeRSNelsonLR, eds. Siminars in neurological surgery. New York: Raven Press, 1979: 95–113.
50.
CottrellJERobustelliAPostKTurndorfH. Furosemide and mannitol-induced changes in intracranial pressure and serum osmolality and electrolytes. Anesthesiology1977; 47: 28–30.
51.
MillsonCJamesHEShapiroHMLaurenR. Intracranial hypertension and brain oedema in albino rabbits. Part 2: Effects of acute therapy with diuretics. Acta Neurochir1981; 56: 167–81.
52.
McCarthyKDReedDJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther1974; 189: 194–201.
53.
BremerAMYamadaKWestCR. Ischemic cerebral edema in primates: Effects of acetazolamide, phenytoin, sorbital, dexamethasone, and methylprednisolone on brain water and electrolytes. Neurosurgery1980; 6: 149–54.
54.
JamesHE. Combination therapy in brain edema. In: Cervos-NavarroJFersztR, eds. Brain edema—pathology, diagnosis and therapy. Advances in neurology. Vol. 28. New York: Raven Press, 1980: 491–501.
55.
BrockMWiengandHZilligCZywitzCMockPDietzH. The effect of dexamethasone on intracranial pressure in patients with supratentorial tumors. In: PappiusHMFeindelW, eds. Dynamics of brain edema. New York: Springer Verlag, 1976: 330–6.
56.
FrenchLAGalicichJH. The use of steroids for control of cerebral edema. Clin Neurosurg1964; 10: 212–23.
57.
EisenbergHMBarlowCFLorenzoA. The effect of dexamethasone on altered brain vascular permeability. Arch Neurol1970; 23: 18–22.
58.
SiegalBAStuderRKPotchenEJ. Steroid therapy for brain edema. Arch Neurol1972; 27: 209–12.
59.
FaupelGReulenHJMullerDShurmannK. Double-blind study on the effects of steroids on severe closed head injury. In: PappiusHMFeindelW, eds. Dynamics of brain edema. New York: Springer Verlag, 1976: 337–43.
60.
GobietWBockWJLiesegangJGroteW. Treatment of acute cerebral edema with high dose dexamethasone. In: BecksJWFBoschDABrockM, eds. Intracranial pressure III. New York: Springer Verlag, 1976: 231–5.
61.
CooperPRMoodySClarkWKDexamethasone and severe head injury. A prospective double-blind study. J Neurosurg1979; 51: 307–16.
62.
GudemanSKMillerJDBeckerDP. Failure of high-dose steroid therapy to influence intracranial pressure in patients with severe head injury. J Neurosurg1979; 51: 301–6.
63.
SaulTGDuckerTBSalcmanMCarroE. Steroids in severe head injury. A prospective randomized clinical trial. J Neurosurg1981; 54: 596–600.
64.
CushingH. Peptic ulcers and the interbrain. Surg Gynecol Obstet1932; 55: 1–34.
65.
MarshallLFKingJLangfittTW. The complications of high-dose corticosteroid therapy in neurosurgical patients. A prospective study. Ann Neurol1977; 1: 201–3.
66.
BassoNBagaraniMMateriaACimetidine and antacid prophylaxis of acute upper gastrointestinal bleeding in high risk patients. Am J Surg1981; 141: 339–41.
67.
PriebeJHSkillmanJJBushnellLSLongPCSilenW. Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients. N Engl J Med1980; 302: 426–30.
68.
GoldsteinAWellsBAKeatsAS. Increased tolerance to cerebral anoxia by pentobarbital. Arch Int Pharmacodyn Ther1966; 161: 138–42.
69.
MichenfelderJDTheyeRA. Cerebral protection by thiopental during hypoxia. Anesthesiology1973; 39: 510–17.
70.
MichenfelderJDTheyeRA. Cerebral protection by barbiturate anesthesia. Arch Neurol1976; 33: 345–50.
71.
SteinPAMildeJHMichenfelderJD. Cerebral metabolic and vascular effects of babiturate therapy following complete global ischemia. J Neurol1978; 31: 1317–24.
72.
NordstromCHSiesjoBK. Effects of phenobarbital in cerebral ischemia. Part 1: Cerebral energy metabolism during pronounced incomplete ischemia. Crit Care Med1978; 9: 327–34.
MarshallLFSmithRWShapiroHM. The outcome with aggressive treatment in severe head injury. Part 2: Acute and chronic barbiturate administration in the management of head injury. J Neurosurg1979; 50: 26–30.
75.
MarshallLFShapiroHMRauscherAKaufmanNM. Pentobarbital therapy for intracranial hypertension in metabolic coma: Reye's syndrome. Crit Care Med1978; 6: 1–5.
76.
VenesJLShaywitzBASpencerDD. Management of severe cerebral edema in the metabolic encephalopathy of Reye-Johnson syndrome. J Neurosurg1978; 48: 903–15.
77.
ReaGLRockswaldGL. Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery1983; 12: 401–4.
78.
QuandtCMde los ReyesRADiazFG. Barbiturate-induced coma for the treatment of cerebral ischemia: Review of outcome. Clin Pharm1982; 1: 549–51.
79.
HarveySC. Hypnotics and sedatives. In: GilmanAGGoodmanLSGilmanA, eds. The pharmacologic basis of therapeutics. New York: Macmillan, 1980: 349–61.
80.
NeuweltEAKikuchiKHillSALyskyPFrenkelE. Barbiturate inhibition of lymphocyte function: Differing effects of various barbiturates used to induce coma. J Neurosurg1982; 56: 254–9.
EhrnaboM. Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration. J Pharm Sci1974; 63: 1114–8.
83.
ReidenbergMMLowenthalDTBriggsWGasparoM. Pentobarbital elimination in patients with poor renal function. Clin Pharmacol Ther1976; 20: 67–71.
84.
DeNicolaLKHayesDP. Phlebothrombosis as a complication of barbiturate induced coma for neuroresuscitation. Drug Intell Clin Pharm1981; 15: 601–2.
85.
HeisslerJFStockmanR. Stability of pentobarbital sodium in small volume admixture. Use in barbiturate coma therapy. American Society of Hospital Pharmacists 16th Annual Midyear Clinical Meeting. December 6–10, 1981, New Orleans (Abstract 371).
86.
BreivikHSafarPSandsP. Clinical feasibility trials of barbiturate therapy after cardiac arrest. Crit Care Med1978; 6: 228–44.
87.
QuandtCMBockbraderHNMillerDA. Thiopental dosage regimen design for patients with intracranial hypertension. American Society of Hospital Pharmacists 15th Annual Midyear Clinical Meeting, December 7–11, 1980, San Francisco (Abstract 220).
88.
ZolaEMCloydJEneverR. Availability of thiopental from I.V. containers. American Society of Hospital Pharmacists 16th Annual Midyear Clinical Meeting, December 6–10, 1981, New Orleans (Abstract 454).
89.
TrisselLA. Handbook on Injectable Drugs. Washington: American Society of Hospital Pharmacists, 1980: 401–7, 517–23.
QuandtCMDiazFGde los ReyesRA. The role of the pharmacist in the management of intracranial hypertension. US Pharmacist1981;(Jan): H2–10.
92.
Use of DMSO for unapproved indications.FDA Drug Bulletin1980; 10: 20–1.
93.
JacobSWWoodDC. Dimethyl sulfoxide (DMSO) toxicology, pharmacology and clinical experience. Am J Surg1967; 114: 414–96.
94.
LahaRKDuhovnyMBarrioneuevoPJDeCastroSCHellstromHRMaroonJC. Protective effects of methylprednisolone and dimethyl sulfoxide in experimental middle cerebral artery embolectomy. J Neurosurg1978; 49: 508–16.
95.
TsurudaJJamesHECampPEWernerR. Acute dimethyl sulfoxide therapy on experimental brain edema. Part 2: Effect of dose and concentration on intracranial pressure, blood pressure, and central venous pressure. Neurosurgery1982; 10: 355–9.
96.
de la TorreJCRowedDWKawanagaHMMullanS. Dimethyl sulfoxide in the treatment of experimental brain compression. J Neurosurg1973; 38: 345–52.
97.
RunckelDNSwansonJR. Effect of dimethyl sulfoxide on serum osmolality. Clin Chem1980; 26: 1745–7.
98.
DMSO in neurosurgery. DMSO report. 1981; 1: 1–8.
99.
DoneganMFBedfordRFDaceyR. Lidocaine for prevention of intracranial hypertension. Anesthesiology1979; 51: S201.
100.
BedfordRFPersingJAPobereskinLButlerA. Lidocaine or thiopental for rapid control of intracranial hypertension. Anesth Analg1980; 59: 435–7.
HimesRSDifazioCABurneyRG. Effects of lidocaine on the anesthetic requirements for nitrous oxide and halothane. Anesthesiology1977; 47: 437–40.
103.
SakabeTMaekawaTIshikawaTTakeshitaH. The effects of lidocaine on canine cerebral metabolism and circulation related to the electroencephalogram. Anesthesiology1974; 40: 433–41.
